Billionaire David Einhorn’s Favorite Healthcare Stock

GREENLIGHT CAPITALOne of the top fund managers at the Value Investing Congress was David Einhorn of Greenlight Capital. Einhorn outlined two short ideas, as well as two long ideas. The biggest Einhorn surprise was an investment thesis for a long position in Cigna Corporation (NYSE:CI). Cigna Corp provides employee benefits, such as healthcare products and services.

During his presentation, Einhorn noted that the added complexity of the company has discouraged investors, but with some effort, the HMOs can be pulled apart and analyzed. Healthcare is a rapidly growing part of the economy, with current HMOs having scale and protection from regulatory hurdles. Part of what makes HMOs tough to analyze is the fact that they re-price every year, but while they may have a bad quarter or year, the business model makes money over the long term.

Cigna’s key acquisition of HealthSpring should help with the company’s growth prospects. HealthSpring allows the company to expand into the Medicare market, as well as increasing commercial members. Full integration of the HealthSpring acquisition should allow Cigna to increase its 2013 EPS to $5.85, up from the estimated 2012 EPS of $5.35. HealthSpring will continue to be a key part of Cigna going forward, namely because millions of Americans are aging into Medicare eligibility each year. HealthSpring allowed Cigna to expand Medicare coverage in eleven states.

Cigna Corp does have tough competition flooding the Medicare-Medicaid industry, with the likes of Aetna Inc. (NYSE:AET) purchasing Coventry Health Care, Inc. (NYSE:CVH). In light of that, Cigna Corp has outperformed year to date, while other key health maintenance organizations have been beaten down. Top Cigna competitors Humana Inc. (NYSE:HUM), WellPoint, Inc. (NYSE:WLP) and Aetna are all in the red year to date. Cigna Corp and UnitedHealth Group Inc. (NYSE:UNH) are both up over 12% year to date.

Aetna and Coventry are joining forces, with Aetna acquiring Coventry for $7.3 billion. The deal should be completed in mid-2013 and Aetna, where Coventry is expected to add $0.45 in 2014 and $0.90 in 2015 to Aetna’s EPS. The acquisition will increase Aetna’s Medicaid, Medicare and individual/small group market presence.

On the other hand, Humana has been struggling with rising medical costs due to higher than expected Medicare beneficiaries selecting Humana’s Medicare Advantage plans. Humana appears to have been too conservative in its 2012 Medicare Advantage bids, and as a result, operating EPS is expected to be down to $7.28 in 2012, compared to $8.46 in 2011.

WellPoint has been struggling with losses in members—with a loss of 375,000 self-funded and 400,000 fully insured members expected in 2012. Like Humana, WellPoint is seeing rising medical costs, which is expected to be up 7%. The other key overhang with WellPoint’s shares is the resignation of the company’s CEO, where the stock down 6% since the CEO’s departure.

UnitedHealth has been performing well compared to other peers, with membership gains and access to the Medicare population, thanks to the acquisition of XLHealth. The acquisition is expected to grow long-term EPS between 13%-16%. Last quarter, David Einhorn took a new position in UnitedHealth, in addition to his Cigna position. The 2.3 million shares that Einhorn bought made up 2% of his 13F portfolio.

Einhorn notes that the big concerns dragging down the other HMOs have little impact on Cigna, including concerns of Obamacare and turmoil in Europe. We believe that Cigna Corp’s current medical costs already reflect the impact of new regulations and the company has a very small international segment, although they have aggressive expansion plans.

Einhorn’s position in Cigna, taken in the second quarter, was a new one for Greenlight Capital, representing over 4% of the firm’s second quarter 13F portfolio. At 6.4 million shares, Einhorn is second to only Maverick Capital for most shares owned by the funds we track. Maverick owned 7.1 million shares at the end of 2Q, which was also over 4% of their 13F holdings.

Cigna appears to have some of the better growth prospects and has showed strong performance amidst a tough economic environment. We agree with Einhorn’s thinking that Cigna Corp has a higher return on capital and growth potential internationally, and as a result, deserves to trade a slight premium to its peers, with a P/E of 11 versus the peer average of 9.5.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!